What does Dr. Frederic Baekelandt do?

Dr. Frederic Baekelandt is a specialist medical practice in Brugge. Private Limited, started on 4 January 2019, 1 establishment.

What is the address of Dr. Frederic Baekelandt?

The registered office of Dr. Frederic Baekelandt is located at Keizer Karelstraat 99, 8000 Brugge.

Is Dr. Frederic Baekelandt still active?

Yes. According to the CBE (30 October 2026) Dr. Frederic Baekelandt is active, legal situation “Normale toestand”, started on 4 January 2019.

Is Dr. Frederic Baekelandt registered on Peppol?

Yes, Dr. Frederic Baekelandt is registered on the Peppol network with ID 0208:0717637672.

What is the enterprise number of Dr. Frederic Baekelandt?

The enterprise number of Dr. Frederic Baekelandt is BE0717637672.

When was Dr. Frederic Baekelandt founded?

Dr. Frederic Baekelandt was founded on 4 January 2019.

Who are the directors of Dr. Frederic Baekelandt?

According to the 2025 annual accounts, the directors of Dr. Frederic Baekelandt are: Frederic Baekelandt.

Is Dr. Frederic Baekelandt a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 January 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Frederic Baekelandt make in 2025?

Dr. Frederic Baekelandt posted a profit after taxes of € 400,646 in financial year 2025.

What is the revenue of Dr. Frederic Baekelandt?

As a small company, Dr. Frederic Baekelandt is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 547,176.

Dr. Frederic Baekelandt (Private Limited) - Brugge

Dossier Dr. Frederic Baekelandt, printed on 30 October 2026 from databakkes.be/en/0717637672/dr-frederic-baekelandt. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Frederic Baekelandt from Brugge, company number BE0717637672, closed financial year 2025 with a result of € 400,646 after tax. For that financial year Dr. Frederic Baekelandt recorded a gross margin of € 547,176 and equity of € 84,582. Compared with financial year 2024, the result moved from € 354,465 to € 400,646. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 13, 2026.

What it is worth Growing

€ 84,582

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 400,646

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 376,953

▲ 62% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 400,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 5,030

▼ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 73,120

▲ € 66,199 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 272,772 Gross margin 2022: € 272,772 First fiscal year in the series	€ 451,720 Gross margin 2023: € 451,720 ▲ 66% vs 2022 (€ 272,772) Favourable step	€ 485,055 Gross margin 2024: € 485,055 ▲ 7% vs 2023 (€ 451,720) Favourable step	€ 547,176 Gross margin 2025: € 547,176 ▲ 13% vs 2024 (€ 485,055) Favourable step	▲ 13%
Profit after taxes	€ 199,380 Profit after taxes 2022: € 199,380 First fiscal year in the series	€ 328,760 Profit after taxes 2023: € 328,760 ▲ 65% vs 2022 (€ 199,380) Favourable step	€ 354,465 Profit after taxes 2024: € 354,465 ▲ 8% vs 2023 (€ 328,760) Favourable step	€ 400,646 Profit after taxes 2025: € 400,646 ▲ 13% vs 2024 (€ 354,465) Favourable step	▲ 13%
Equity	€ 18,710 Equity 2022: € 18,710 First fiscal year in the series	€ 19,471 Equity 2023: € 19,471 ▲ 4% vs 2022 (€ 18,710) Favourable step	€ 83,936 Equity 2024: € 83,936 ▲ € 64,465 vs 2023 (€ 19,471) Favourable step	€ 84,582 Equity 2025: € 84,582 ▲ 1% vs 2024 (€ 83,936) Favourable step	▲ 1%
Total debts	€ 234,886 Total debts 2022: € 234,886 First fiscal year in the series	€ 314,667 Total debts 2023: € 314,667 ▲ 34% vs 2022 (€ 234,886) Unfavourable step	€ 251,163 Total debts 2024: € 251,163 ▼ 20% vs 2023 (€ 314,667) Favourable step	€ 413,120 Total debts 2025: € 413,120 ▲ 64% vs 2024 (€ 251,163) Unfavourable step	▲ 64%
Cash	€ 133,506 Cash 2022: € 133,506 First fiscal year in the series	€ 214,495 Cash 2023: € 214,495 ▲ 61% vs 2022 (€ 133,506) Favourable step	€ 232,465 Cash 2024: € 232,465 ▲ 8% vs 2023 (€ 214,495) Favourable step	€ 376,953 Cash 2025: € 376,953 ▲ 62% vs 2024 (€ 232,465) Favourable step	▲ 62%
Land & buildings	-	€ 14,739 Land & buildings 2023: € 14,739 First fiscal year in the series	€ 20,359 Land & buildings 2024: € 20,359 ▲ 38% vs 2023 (€ 14,739) Unchanged	€ 33,998 Land & buildings 2025: € 33,998 ▲ 67% vs 2024 (€ 20,359) Unchanged	▲ 67%
Retained profit	€ 110 Retained profit 2022: € 110 First fiscal year in the series	€ 871 Retained profit 2023: € 871 ▲ € 760 vs 2022 (€ 110) Favourable step	€ 65,336 Retained profit 2024: € 65,336 ▲ € 64,465 vs 2023 (€ 871) Favourable step	€ 65,982 Retained profit 2025: € 65,982 ▲ 1% vs 2024 (€ 65,336) Favourable step	▲ 1%
Dividend	€ 279,000 Dividend 2022: € 279,000 First fiscal year in the series	€ 328,000 Dividend 2023: € 328,000 ▲ 18% vs 2022 (€ 279,000) Unchanged	€ 290,000 Dividend 2024: € 290,000 ▼ 12% vs 2023 (€ 328,000) Unchanged	€ 400,000 Dividend 2025: € 400,000 ▲ 38% vs 2024 (€ 290,000) Unchanged	▲ 38%
Bank debt	€ 33,156 Bank debt 2022: € 33,156 First fiscal year in the series	€ 18,028 Bank debt 2023: € 18,028 ▼ 46% vs 2022 (€ 33,156) Favourable step	€ 3,890 Bank debt 2024: € 3,890 ▼ 78% vs 2023 (€ 18,028) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 3,890) Favourable step	▼ 100%
Balance sheet total	€ 253,596 Balance sheet total 2022: € 253,596 First fiscal year in the series	€ 334,137 Balance sheet total 2023: € 334,137 ▲ 32% vs 2022 (€ 253,596) Unchanged	€ 335,099 Balance sheet total 2024: € 335,099 Unchanged (€ 334,137) Unchanged	€ 497,702 Balance sheet total 2025: € 497,702 ▲ 49% vs 2024 (€ 335,099) Unchanged	▲ 49%

Key figures of Dr. Frederic Baekelandt, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Frederic Baekelandt?

What happened at Dr. Frederic Baekelandt in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 13, 2026 New annual accounts for financial year 2025: profit of € 400,646 (▲ 13% vs 2024). Source: NBB ↗
Jan 4, 2019 New establishment in Brugge. KBO
Jan 4, 2019 Start of the company according to the CBE. KBO

In short

From € 199,380 profit in 2022 to € 400,646 profit in 2025.

Paid € 408,407 in corporate taxes since 2022.

Best year ever: 2025, with € 400,646 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frederic Baekelandt

Dr. Frederic Baekelandt

Behind Dr. Frederic Baekelandt is Frederic Baekelandt.

Directors

According to the 2025 annual accounts

Frederic Baekelandt

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Keizer Karelstraat 99

8000 Brugge

2.283.593.992

Gouden-Boomstraat 35

8000 Brugge

Active since 4 January 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0717.637.672
VAT number: BE 0717.637.672
Registered office: Keizer Karelstraat 99, 8000 Brugge
Names & denominations: Dr. Frederic Baekelandt
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 January 2019
Peppol: Active · Active since 4 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗